Juvisé Pharmaceuticals
https://www.juvisepharmaceuticals.com/?lang=fr
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Juvisé Pharmaceuticals
Deal Watch: Gilead Acquires Xilio’s IL-12 Activating Candidate
Plus deals involving Avalo/AlmataBio, AbbVie/Parvus, NovaBay/Eyenovia, Bayer/Aignostics, Merck & Co./Pearl, tech transfer agreements and deals in brief.
Company Information
- Industry
- Biotechnology
- Other Names / Subsidiaries
-
- Juvise Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice